nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PDPK1—renal system—rectum cancer	0.0334	0.0655	CbGeAlD
Celecoxib—PDPK1—female reproductive system—rectum cancer	0.0268	0.0524	CbGeAlD
Celecoxib—CA5A—female reproductive system—rectum cancer	0.0251	0.0492	CbGeAlD
Celecoxib—PDPK1—vagina—rectum cancer	0.0242	0.0474	CbGeAlD
Celecoxib—CA14—seminal vesicle—rectum cancer	0.0216	0.0423	CbGeAlD
Celecoxib—MAPK14—epithelium—rectum cancer	0.0193	0.0377	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—rectum cancer	0.0186	0.0364	CbGeAlD
Celecoxib—MAPK14—renal system—rectum cancer	0.0179	0.035	CbGeAlD
Celecoxib—PDPK1—lymph node—rectum cancer	0.0157	0.0307	CbGeAlD
Celecoxib—CA9—female reproductive system—rectum cancer	0.0147	0.0288	CbGeAlD
Celecoxib—MAPK14—female reproductive system—rectum cancer	0.0143	0.028	CbGeAlD
Celecoxib—CA12—renal system—rectum cancer	0.0136	0.0266	CbGeAlD
Celecoxib—MAPK14—vagina—rectum cancer	0.013	0.0254	CbGeAlD
Celecoxib—CA5B—urethra—rectum cancer	0.012	0.0234	CbGeAlD
Celecoxib—CA5B—mammalian vulva—rectum cancer	0.0114	0.0223	CbGeAlD
Celecoxib—CA12—female reproductive system—rectum cancer	0.0109	0.0213	CbGeAlD
Celecoxib—CA4—seminal vesicle—rectum cancer	0.0104	0.0204	CbGeAlD
Celecoxib—CA5B—female reproductive system—rectum cancer	0.00975	0.0191	CbGeAlD
Celecoxib—ABCC4—renal system—rectum cancer	0.00914	0.0179	CbGeAlD
Celecoxib—CA5B—vagina—rectum cancer	0.00882	0.0173	CbGeAlD
Celecoxib—CA2—seminal vesicle—rectum cancer	0.00865	0.0169	CbGeAlD
Celecoxib—ORM1—female reproductive system—rectum cancer	0.00862	0.0169	CbGeAlD
Celecoxib—CA4—renal system—rectum cancer	0.0084	0.0164	CbGeAlD
Celecoxib—MAPK14—lymph node—rectum cancer	0.00838	0.0164	CbGeAlD
Celecoxib—CA4—urethra—rectum cancer	0.00825	0.0162	CbGeAlD
Celecoxib—CA2—epithelium—rectum cancer	0.00751	0.0147	CbGeAlD
Celecoxib—ABCC4—female reproductive system—rectum cancer	0.00732	0.0143	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—rectum cancer	0.00724	0.0142	CbGeAlD
Celecoxib—CA2—renal system—rectum cancer	0.00697	0.0136	CbGeAlD
Celecoxib—CA4—female reproductive system—rectum cancer	0.00673	0.0132	CbGeAlD
Celecoxib—CA2—mammalian vulva—rectum cancer	0.00652	0.0128	CbGeAlD
Celecoxib—PTGS2—seminal vesicle—rectum cancer	0.00638	0.0125	CbGeAlD
Celecoxib—CA5B—lymph node—rectum cancer	0.0057	0.0112	CbGeAlD
Celecoxib—CA2—female reproductive system—rectum cancer	0.00558	0.0109	CbGeAlD
Celecoxib—PTGS2—epithelium—rectum cancer	0.00555	0.0109	CbGeAlD
Celecoxib—PTGS2—smooth muscle tissue—rectum cancer	0.00534	0.0105	CbGeAlD
Celecoxib—PTGS2—renal system—rectum cancer	0.00514	0.0101	CbGeAlD
Celecoxib—PTGS2—urethra—rectum cancer	0.00505	0.00989	CbGeAlD
Celecoxib—CA2—vagina—rectum cancer	0.00505	0.00988	CbGeAlD
Celecoxib—ORM1—lymph node—rectum cancer	0.00504	0.00987	CbGeAlD
Celecoxib—CYP2C9—female reproductive system—rectum cancer	0.00472	0.00924	CbGeAlD
Celecoxib—CYP3A4—renal system—rectum cancer	0.00449	0.0088	CbGeAlD
Celecoxib—ALB—lymph node—rectum cancer	0.00442	0.00866	CbGeAlD
Celecoxib—CYP2D6—renal system—rectum cancer	0.00442	0.00866	CbGeAlD
Celecoxib—ABCC4—lymph node—rectum cancer	0.00428	0.00838	CbGeAlD
Celecoxib—PTGS2—female reproductive system—rectum cancer	0.00412	0.00806	CbGeAlD
Celecoxib—CA4—lymph node—rectum cancer	0.00394	0.00771	CbGeAlD
Celecoxib—PTGS2—vagina—rectum cancer	0.00373	0.00729	CbGeAlD
Celecoxib—CYP3A4—female reproductive system—rectum cancer	0.0036	0.00705	CbGeAlD
Celecoxib—CYP2D6—female reproductive system—rectum cancer	0.00354	0.00693	CbGeAlD
Celecoxib—CA2—lymph node—rectum cancer	0.00326	0.00639	CbGeAlD
Celecoxib—PDPK1—mTOR signaling pathway—KRAS—rectum cancer	0.00281	0.00575	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00277	0.00567	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—NRAS—rectum cancer	0.00275	0.00561	CbGpPWpGaD
Celecoxib—PDPK1—IRS-mediated signalling—NRAS—rectum cancer	0.00267	0.00546	CbGpPWpGaD
Celecoxib—MAPK14—CXCR3-mediated signaling events—NRAS—rectum cancer	0.00264	0.0054	CbGpPWpGaD
Celecoxib—PDPK1—IRS-related events—NRAS—rectum cancer	0.0026	0.00531	CbGpPWpGaD
Celecoxib—ABCC4—Fluoropyrimidine Activity—TP53—rectum cancer	0.00258	0.00528	CbGpPWpGaD
Celecoxib—PDPK1—IRS-related events triggered by IGF1R—NRAS—rectum cancer	0.00257	0.00526	CbGpPWpGaD
Celecoxib—PDPK1—IGF1R signaling cascade—NRAS—rectum cancer	0.0025	0.00512	CbGpPWpGaD
Celecoxib—PDPK1—Insulin receptor signalling cascade—NRAS—rectum cancer	0.0025	0.00512	CbGpPWpGaD
Celecoxib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—KRAS—rectum cancer	0.00248	0.00508	CbGpPWpGaD
Celecoxib—MAPK14—Signalling to RAS—KRAS—rectum cancer	0.00248	0.00508	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00247	0.00505	CbGpPWpGaD
Celecoxib—MAPK14—Nanoparticle-mediated activation of receptor signaling—HRAS—rectum cancer	0.00247	0.00504	CbGpPWpGaD
Celecoxib—PTGS2—lymph node—rectum cancer	0.00241	0.00472	CbGeAlD
Celecoxib—MAPK14—MAPK Cascade—HRAS—rectum cancer	0.0024	0.0049	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling in naïve CD4+ T cells—HRAS—rectum cancer	0.00239	0.00489	CbGpPWpGaD
Celecoxib—PDPK1—mTOR signaling pathway—HRAS—rectum cancer	0.00239	0.00489	CbGpPWpGaD
Celecoxib—PDPK1—TSH signaling pathway—HRAS—rectum cancer	0.00239	0.00489	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—KRAS—rectum cancer	0.00236	0.00483	CbGpPWpGaD
Celecoxib—PDPK1—BCR signaling pathway—HRAS—rectum cancer	0.00236	0.00483	CbGpPWpGaD
Celecoxib—MAPK14—Signalling to ERKs—NRAS—rectum cancer	0.00235	0.0048	CbGpPWpGaD
Celecoxib—PDPK1—IRS-mediated signalling—KRAS—rectum cancer	0.0023	0.0047	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—ITGA2—rectum cancer	0.00228	0.00466	CbGpPWpGaD
Celecoxib—MAPK14—CXCR3-mediated signaling events—KRAS—rectum cancer	0.00227	0.00465	CbGpPWpGaD
Celecoxib—PDPK1—ErbB1 downstream signaling—NRAS—rectum cancer	0.00225	0.00461	CbGpPWpGaD
Celecoxib—PDPK1—IRS-related events—KRAS—rectum cancer	0.00223	0.00457	CbGpPWpGaD
Celecoxib—PDPK1—VEGFA-VEGFR2 Pathway—NRAS—rectum cancer	0.00222	0.00454	CbGpPWpGaD
Celecoxib—MAPK14—EPO signaling pathway—HRAS—rectum cancer	0.00222	0.00453	CbGpPWpGaD
Celecoxib—PDPK1—IRS-related events triggered by IGF1R—KRAS—rectum cancer	0.00221	0.00453	CbGpPWpGaD
Celecoxib—MAPK14—Alpha 6 Beta 4 signaling pathway—HRAS—rectum cancer	0.00216	0.00442	CbGpPWpGaD
Celecoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	0.00216	0.00441	CbGpPWpGaD
Celecoxib—PDPK1—Insulin receptor signalling cascade—KRAS—rectum cancer	0.00216	0.00441	CbGpPWpGaD
Celecoxib—PDPK1—IGF1R signaling cascade—KRAS—rectum cancer	0.00216	0.00441	CbGpPWpGaD
Celecoxib—MAPK14—Signalling to RAS—HRAS—rectum cancer	0.00211	0.00432	CbGpPWpGaD
Celecoxib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—HRAS—rectum cancer	0.00211	0.00432	CbGpPWpGaD
Celecoxib—MAPK14—p38 MAPK Signaling Pathway—HRAS—rectum cancer	0.00211	0.00432	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—TP53—rectum cancer	0.0021	0.00429	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by VEGF—NRAS—rectum cancer	0.00209	0.00428	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by Insulin receptor—NRAS—rectum cancer	0.00208	0.00425	CbGpPWpGaD
Celecoxib—PDPK1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—rectum cancer	0.00205	0.00419	CbGpPWpGaD
Celecoxib—MAPK14—Signalling to ERKs—KRAS—rectum cancer	0.00202	0.00413	CbGpPWpGaD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—rectum cancer	0.00202	0.00413	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—HRAS—rectum cancer	0.00201	0.00411	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—NRAS—rectum cancer	0.00199	0.00408	CbGpPWpGaD
Celecoxib—PDPK1—IRS-mediated signalling—HRAS—rectum cancer	0.00195	0.00399	CbGpPWpGaD
Celecoxib—PDPK1—ErbB1 downstream signaling—KRAS—rectum cancer	0.00194	0.00396	CbGpPWpGaD
Celecoxib—MAPK14—CXCR3-mediated signaling events—HRAS—rectum cancer	0.00193	0.00395	CbGpPWpGaD
Celecoxib—PDPK1—VEGFA-VEGFR2 Pathway—KRAS—rectum cancer	0.00191	0.00391	CbGpPWpGaD
Celecoxib—PDPK1—IRS-related events—HRAS—rectum cancer	0.0019	0.00388	CbGpPWpGaD
Celecoxib—PDPK1—IRS-related events triggered by IGF1R—HRAS—rectum cancer	0.00188	0.00385	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—HRAS—rectum cancer	0.00186	0.00381	CbGpPWpGaD
Celecoxib—PDPK1—Insulin receptor signalling cascade—HRAS—rectum cancer	0.00183	0.00375	CbGpPWpGaD
Celecoxib—PDPK1—IGF1R signaling cascade—HRAS—rectum cancer	0.00183	0.00375	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by VEGF—KRAS—rectum cancer	0.0018	0.00369	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by Insulin receptor—KRAS—rectum cancer	0.00179	0.00366	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—NRAS—rectum cancer	0.00178	0.00364	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	0.00176	0.00359	CbGpPWpGaD
Celecoxib—MAPK14—Signalling to ERKs—HRAS—rectum cancer	0.00172	0.00351	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—KRAS—rectum cancer	0.00172	0.00351	CbGpPWpGaD
Celecoxib—PDPK1—Integrin-mediated Cell Adhesion—HRAS—rectum cancer	0.00171	0.0035	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—NRAS—rectum cancer	0.0017	0.00348	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	0.00168	0.00343	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—NRAS—rectum cancer	0.00168	0.00343	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00167	0.00342	CbGpPWpGaD
Celecoxib—PDPK1—ErbB1 downstream signaling—HRAS—rectum cancer	0.00165	0.00337	CbGpPWpGaD
Celecoxib—PDPK1—VEGFA-VEGFR2 Pathway—HRAS—rectum cancer	0.00162	0.00332	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signal transduction—NRAS—rectum cancer	0.0016	0.00327	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—NRAS—rectum cancer	0.00159	0.00326	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB2—NRAS—rectum cancer	0.00158	0.00324	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—NRAS—rectum cancer	0.00158	0.00322	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	0.00155	0.00318	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by VEGF—HRAS—rectum cancer	0.00153	0.00313	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—KRAS—rectum cancer	0.00153	0.00313	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by Insulin receptor—HRAS—rectum cancer	0.00152	0.00311	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.00148	0.00303	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—NRAS—rectum cancer	0.00148	0.00303	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—NRAS—rectum cancer	0.00148	0.00303	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—KRAS—rectum cancer	0.00148	0.00302	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR—NRAS—rectum cancer	0.00147	0.00301	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.00147	0.003	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—HRAS—rectum cancer	0.00146	0.00298	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.00146	0.00298	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—NRAS—rectum cancer	0.00145	0.00297	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00145	0.00296	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	0.00144	0.00295	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—KRAS—rectum cancer	0.00144	0.00295	CbGpPWpGaD
Celecoxib—MAPK14—p53 pathway—TP53—rectum cancer	0.00142	0.0029	CbGpPWpGaD
Celecoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	0.00138	0.00282	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signal transduction—KRAS—rectum cancer	0.00138	0.00282	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—NRAS—rectum cancer	0.00137	0.00281	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—KRAS—rectum cancer	0.00137	0.0028	CbGpPWpGaD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.00137	0.0028	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB2—KRAS—rectum cancer	0.00136	0.00279	CbGpPWpGaD
Celecoxib—MAPK14—Kit receptor signaling pathway—HRAS—rectum cancer	0.00136	0.00278	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—KRAS—rectum cancer	0.00136	0.00278	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ITGA2—rectum cancer	0.00135	0.00277	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.00134	0.00274	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—rectum cancer	0.00131	0.00269	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.00131	0.00269	CbGpPWpGaD
Celecoxib—PDPK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	0.00131	0.00268	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—HRAS—rectum cancer	0.0013	0.00266	CbGpPWpGaD
Celecoxib—MAPK14—Endothelins—HRAS—rectum cancer	0.00129	0.00264	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	0.00128	0.00262	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—HRAS—rectum cancer	0.00128	0.00262	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—KRAS—rectum cancer	0.00128	0.00261	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—KRAS—rectum cancer	0.00128	0.00261	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.00128	0.00261	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR—KRAS—rectum cancer	0.00127	0.00259	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—HRAS—rectum cancer	0.00126	0.00257	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.00125	0.00256	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00125	0.00256	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—KRAS—rectum cancer	0.00125	0.00255	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.00125	0.00255	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.00125	0.00255	CbGpPWpGaD
Celecoxib—MAPK14—TSH signaling pathway—HRAS—rectum cancer	0.00124	0.00254	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	0.00123	0.00251	CbGpPWpGaD
Celecoxib—MAPK14—BCR signaling pathway—HRAS—rectum cancer	0.00123	0.00251	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—HRAS—rectum cancer	0.00123	0.00251	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—ITGA2—rectum cancer	0.00121	0.00247	CbGpPWpGaD
Celecoxib—MAPK14—CDC42 signaling events—HRAS—rectum cancer	0.00118	0.00242	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ITGA2—rectum cancer	0.00118	0.00242	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—KRAS—rectum cancer	0.00118	0.00242	CbGpPWpGaD
Celecoxib—PDPK1—Insulin Signaling—HRAS—rectum cancer	0.00118	0.00241	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signal transduction—HRAS—rectum cancer	0.00117	0.00239	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—HRAS—rectum cancer	0.00117	0.00238	CbGpPWpGaD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.00117	0.00238	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB2—HRAS—rectum cancer	0.00116	0.00237	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—HRAS—rectum cancer	0.00115	0.00236	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—NRAS—rectum cancer	0.00115	0.00236	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.00114	0.00232	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.00113	0.00231	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—HRAS—rectum cancer	0.00112	0.00229	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—rectum cancer	0.00109	0.00223	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—NRAS—rectum cancer	0.00109	0.00223	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—HRAS—rectum cancer	0.00109	0.00222	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—HRAS—rectum cancer	0.00109	0.00222	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.00109	0.00222	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR—HRAS—rectum cancer	0.00108	0.0022	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00107	0.00219	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.00107	0.00218	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—HRAS—rectum cancer	0.00106	0.00217	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00106	0.00217	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—HRAS—rectum cancer	0.00103	0.0021	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—NRAS—rectum cancer	0.00101	0.00207	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—HRAS—rectum cancer	0.001	0.00205	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—KRAS—rectum cancer	0.000993	0.00203	CbGpPWpGaD
Celecoxib—PDPK1—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000984	0.00201	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—HRAS—rectum cancer	0.000969	0.00198	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000961	0.00197	CbGpPWpGaD
Celecoxib—CA14—Metabolism—TYMS—rectum cancer	0.00095	0.00194	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—KRAS—rectum cancer	0.000937	0.00192	CbGpPWpGaD
Celecoxib—CA6—Metabolism—TYMS—rectum cancer	0.000925	0.00189	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—TYMS—rectum cancer	0.000925	0.00189	CbGpPWpGaD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	0.000913	0.00187	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—rectum cancer	0.000896	0.00183	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—NRAS—rectum cancer	0.000894	0.00183	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—KRAS—rectum cancer	0.00087	0.00178	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—TYMS—rectum cancer	0.000864	0.00177	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—HRAS—rectum cancer	0.000857	0.00175	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—HRAS—rectum cancer	0.000844	0.00173	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—rectum cancer	0.00081	0.00166	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—NRAS—rectum cancer	0.000804	0.00164	CbGpPWpGaD
Celecoxib—CA12—Metabolism—TYMS—rectum cancer	0.0008	0.00164	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—HRAS—rectum cancer	0.000796	0.00163	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—KRAS—rectum cancer	0.00077	0.00157	CbGpPWpGaD
Celecoxib—PDPK1—Neuronal System—HRAS—rectum cancer	0.000754	0.00154	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—rectum cancer	0.000746	0.00152	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—HRAS—rectum cancer	0.000739	0.00151	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.000712	0.00146	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—rectum cancer	0.00071	0.00145	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—KRAS—rectum cancer	0.000692	0.00141	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000683	0.0014	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—rectum cancer	0.000671	0.00137	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—HRAS—rectum cancer	0.000665	0.00136	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—HRAS—rectum cancer	0.000654	0.00134	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—NRAS—rectum cancer	0.00064	0.00131	CbGpPWpGaD
Celecoxib—CA4—Metabolism—TYMS—rectum cancer	0.000638	0.0013	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000624	0.00128	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—rectum cancer	0.000615	0.00126	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ITGA2—rectum cancer	0.000612	0.00125	CbGpPWpGaD
Celecoxib—CA2—Metabolism—TYMS—rectum cancer	0.000612	0.00125	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—rectum cancer	0.000612	0.00125	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000605	0.00124	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000588	0.0012	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NRAS—rectum cancer	0.000576	0.00118	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—rectum cancer	0.000567	0.00116	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000555	0.00113	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NRAS—rectum cancer	0.000554	0.00113	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—KRAS—rectum cancer	0.000551	0.00113	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NRAS—rectum cancer	0.000525	0.00107	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—rectum cancer	0.000521	0.00107	CbGpPWpGaD
Celecoxib—CA9—Metabolism—TYMS—rectum cancer	0.000516	0.00105	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.0005	0.00102	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KRAS—rectum cancer	0.000496	0.00101	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—rectum cancer	0.00049	0.001	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—KRAS—rectum cancer	0.000476	0.000974	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—rectum cancer	0.000468	0.000958	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KRAS—rectum cancer	0.000452	0.000924	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—rectum cancer	0.000428	0.000876	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—rectum cancer	0.000422	0.000862	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—rectum cancer	0.000405	0.000828	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000399	0.000816	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—rectum cancer	0.000384	0.000786	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NRAS—rectum cancer	0.00038	0.000777	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—NRAS—rectum cancer	0.000367	0.000751	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000355	0.000725	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NRAS—rectum cancer	0.000339	0.000694	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NRAS—rectum cancer	0.000336	0.000686	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NRAS—rectum cancer	0.000333	0.00068	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—KRAS—rectum cancer	0.000327	0.000669	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—KRAS—rectum cancer	0.000316	0.000647	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NRAS—rectum cancer	0.00031	0.000634	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NRAS—rectum cancer	0.0003	0.000613	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—KRAS—rectum cancer	0.000292	0.000597	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—rectum cancer	0.000291	0.000594	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KRAS—rectum cancer	0.000289	0.000591	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—KRAS—rectum cancer	0.000286	0.000586	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—rectum cancer	0.000278	0.000569	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—rectum cancer	0.000269	0.00055	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KRAS—rectum cancer	0.000267	0.000546	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KRAS—rectum cancer	0.000258	0.000527	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—rectum cancer	0.000255	0.00052	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—rectum cancer	0.000248	0.000507	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—rectum cancer	0.000246	0.000502	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—rectum cancer	0.000243	0.000498	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—rectum cancer	0.000227	0.000464	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—rectum cancer	0.000219	0.000448	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NRAS—rectum cancer	0.000217	0.000444	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TYMS—rectum cancer	0.000199	0.000406	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KRAS—rectum cancer	0.000187	0.000382	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRAS—rectum cancer	0.000174	0.000357	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NRAS—rectum cancer	0.000172	0.000352	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—rectum cancer	0.000166	0.00034	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TYMS—rectum cancer	0.000161	0.000329	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—rectum cancer	0.000159	0.000325	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KRAS—rectum cancer	0.00015	0.000307	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KRAS—rectum cancer	0.000148	0.000303	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TYMS—rectum cancer	0.000133	0.000271	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TYMS—rectum cancer	0.000132	0.000269	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—rectum cancer	0.000132	0.000269	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—rectum cancer	0.000128	0.000261	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—rectum cancer	0.000126	0.000257	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRAS—rectum cancer	0.000113	0.000231	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRAS—rectum cancer	0.000103	0.00021	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KRAS—rectum cancer	9.71e-05	0.000199	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KRAS—rectum cancer	8.86e-05	0.000181	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TYMS—rectum cancer	8.68e-05	0.000178	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—rectum cancer	8.63e-05	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—rectum cancer	8.25e-05	0.000169	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—rectum cancer	7.53e-05	0.000154	CbGpPWpGaD
